Nwk Group, Inc. Gilead Sciences, Inc. Transaction History

Nwk Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $190 - $208	-3 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $1,133 - $1,291	-20 Reduced 86.96%	3 $0
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $3,291 - $4,138	-53 Reduced 69.74%	23 $1,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $5,497 - $6,384	76 New	76 $6,000

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.